SKAGEN Global D (CHF)Register to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 9.8 | 32.6 | -13.3 | 11.8 | 7.7 | |
+/-Cat | -13.9 | 18.0 | 4.8 | -4.3 | -3.7 | |
+/-B’mrk | - | 14.5 | 5.7 | -10.5 | -9.3 | |
Category: Global Large-Cap Growth Equity | ||||||
Category Benchmark: Morningstar Gbl Growth TME ... |
Key Stats | ||
NAV 21/11/2024 | CHF 329.93 | |
Day Change | 0.96% | |
Morningstar Category™ | Global Large-Cap Growth Equity | |
ISIN | NO0010723323 | |
Fund Size (Mil) 31/10/2024 | NOK 41156.97 | |
Share Class Size (Mil) 31/10/2024 | NOK 1.63 | |
Max Initial Charge | 1.00% | |
Ongoing Charge 01/10/2024 | 0.50% |
Investment Objective: SKAGEN Global D (CHF) |
The fund’s objective is to provide the unit holders with the best possible return based on the risk they have undertaken through an actively managed portfolio of international equities. SKAGEN Global has a worldwide investment mandate. The fund’s aim is to find high quality companies at a low price, which are characterized by being undervalued, under-researched and unpopular. To reduce risk, the fund seeks to maintain a sensible geographical and sector balance. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Knut Gezelius 01/05/2014 | ||
Chris-Tommy Simonsen 01/01/2008 | ||
Inception Date 01/01/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI NR USD | Morningstar Gbl Growth TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for SKAGEN Global D (CHF) | 31/10/2024 |
|
|
Top 5 Holdings | Sector | % |
DSV AS | Industrials | 7.02 |
Canadian Pacific Kansas City Ltd | Industrials | 6.95 |
Abbott Laboratories | Healthcare | 5.54 |
Alphabet Inc Class C | Communication Services | 5.33 |
Moodys Corp | Financial Services | 4.91 |
Increase Decrease New since last portfolio | ||
SKAGEN Global D (CHF) |